Vergoeding 2016-2020 voor ATC-subgroep J05AG : Niet-nucleoside reverse-transcriptaseremmers
- Raming voor de totale Zvw-populatie
| 2016 | 2017 | 2018 | 2019 | 2020 | |
|---|---|---|---|---|---|
| J05AG01 Nevirapine (Viramune ®) | 6.306.700 | 4.919.800 | 2.800.800 | 1.755.600 | 1.488.100 |
| J05AG03 Efavirenz (Stocrin ®) | 787.280 | 618.020 | 514.910 | 424.280 | 354.370 |
| J05AG04 Etravirine (Intelence ®) | 1.052.000 | 856.290 | 720.070 | 595.730 | 477.850 |
| J05AG05 Rilpivirine (Edurant ®) | 254.600 | 289.980 | 313.950 | 295.630 | 267.870 |
| J05AG06 Doravirine (Pifeltro ®) | . | . | . | 12.972 | 261.430 |
| Totaal | 8.400.580 | 6.684.090 | 4.349.730 | 3.084.212 | 2.849.620 |